Usage of topical insulin for the treatment of diabetic keratopathy, including corneal epithelial defects

Ching Yee Leong,Ainal Adlin Naffi,Wan Haslina Wan Abdul Halim,Mae-Lynn Catherine Bastion

DOI: https://doi.org/10.4239/wjd.v14.i6.930

2023-06-15

World Journal of Diabetes

Abstract:BACKGROUND Diabetic keratopathy (DK) occurs in 46%-64% of patients with diabetes and requires serious attention. In patients with diabetes, the healing of corneal epithelial defects or ulcers takes longer than in patients without diabetes. Insulin is an effective factor in wound healing. The ability of systemic insulin to rapidly heal burn wounds has been reported for nearly a century, but only a few studies have been performed on the effects of topical insulin (TI) on the eye. Treatment with TI is effective in treating DK. AIM To review clinical and experimental animal studies providing evidence for the efficacy of TI to heal corneal wounds. METHODS National and international databases, including PubMed and Scopus, were searched using relevant keywords, and additional manual searches were conducted to assess the effectiveness of TI application on corneal wound healing. Journal articles published from January 1, 2000 to December 1, 2022 were examined. The relevancy of the identified citations was checked against predetermined eligibility standards, and relevant articles were extracted and reviewed. RESULTS A total of eight articles were found relevant to be discussed in this review, including four animal studies and four clinical studies. According to the studies conducted, TI is effective for corneal re-epithelialization in patients with diabetes based on corneal wound size and healing rate. CONCLUSION Available animal and clinical studies have shown that TI promotes corneal wound healing by several mechanisms. The use of TI was not associated with adverse effects in any of the published cases. Further studies are needed to enhance our knowledge and understanding of TI in the healing of DK. Key Words: Diabetes mellitus, Diabetic keratopathy, Topical insulin, Healing Core Tip: Diabetic keratopathy (DK) is a common complication of diabetes mellitus that is responsible for poor corneal wound healing. It also reduces quality of vision and quality of life. DK is the result of damage resulting from insulin deficiency, hyperglycemia and neuropathy. Topical insulin has been described as an effective and safe new treatment for DK that can normalize the ocular surface and healing rate of epithelial defects. This review examines the available evidence. Citation: Leong CY, Naffi AA, Wan Abdul Halim WH, Bastion MLC. Usage of topical insulin for the treatment of diabetic keratopathy, including corneal epithelial defects. World J Diabetes 2023; 14(6): 930-938 URL: https://www.wjgnet.com/1948-9358/full/v14/i6/930.htm DOI: https://dx.doi.org/10.4239/wjd.v14.i6.930

endocrinology & metabolism